BioNTech SE (BNTX) Treasury Shares (2019 - 2026)

BioNTech SE has reported Treasury Shares for 7 years, with the latest figure at $9.0 million in Q4 2025.

• Quarterly Treasury Shares fell 2.47% year-over-year to $9.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.0 million (down 2.47% YoY) and the FY2025 annual result came in at $8.7 million, down 5.34% from the prior year.
• Treasury Shares improved to $9.0 million in Q4 2025 per BNTX's latest filing, from -$9.5 million in the prior quarter.
• Over five years, Treasury Shares peaked at $9.2 million in Q4 2024 and troughed at -$938.4 million in Q3 2022.
• A 5-year average of -$204.5 million and a median of -$9.6 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares sank 14594.58% in 2023, then soared 101.16% in 2024.
• Over 5 years, Treasury Shares stood at -$4.3 million in 2021, then slipped by 24.39% to -$5.4 million in 2022, then tumbled by 14594.58% to -$794.6 million in 2023, then surged by 101.16% to $9.2 million in 2024, then decreased by 2.47% to $9.0 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $9.0 million, -$9.5 million, and -$9.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.